https://www.selleckchem.com/pr....oducts/as1517499.htm
Intracranial progression is considered an important cause of treatment failure in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) patients. Recent advances in targeted therapy and radiomics have generated considerable interest for the exploration of prognostic imaging biomarkers to predict the clinical course. Here, we developed a magnetic resonance imaging (MRI) radiomic signature that can stratify survival and intracranial progression. We analyzed 87 brain metastatic lesions in 24 ALK-positive NSCLC pati
Like
Comment
Share
